here come more layoffs

Quote




















Anonymous said:
Hopefully this is not happening again.
Click to expand...

I would not be pessimistic. They have to make sales plans. After all, there are new products to release. If it was happening again, what would you be doing about it or what would you be doing differently? Be prepared by following up on these two questions. The best defense is a good offense!
 




Ah yes ....sales plans ......call them that if you wish. How about layoff plans ? Remember Pargluva was voted favorably by 9 to 1the by the FDA advisory committee. Remember what happened? On the other hand, dapa got voted 9 to 6 against. Gentleman place your bets..,.
 








Anonymous said:
Ah yes ....sales plans ......call them that if you wish. How about layoff plans ? Remember Pargluva was voted favorably by 9 to 1the by the FDA advisory committee. Remember what happened? On the other hand, dapa got voted 9 to 6 against. Gentleman place your bets..,.
Click to expand...

How can you possibly think this drug will get approved on first run considering 9 to 6 negative vote, blabber and breast cancer, a negative signal concerning liver toxicity, and urinary tract infections. The FDA would be crazy to approve without evaluating further
 




Dapa will get approved with post marketing studies required!! Studies that we have submitted to the FDA show the cancer was most likely there already there. God reps are so clueless about what goes on real in the real world.
 




Anonymous said:
Dapa will get approved with post marketing studies required!! Studies that we have submitted to the FDA show the cancer was most likely there already there. God reps are so clueless about what goes on real in the real world.
Click to expand...

there already there. goes on real in the real world. This asshole cannot even write a sentence. Agree with the other pollster with hy law governing liver toxicity and potential cancers, the FDA will probably delay. Look what they did with Effient which did not have near the problems. This drug will be a disaster
 




Anonymous said:
Dapa will get approved with post marketing studies required!! Studies that we have submitted to the FDA show the cancer was most likely there already there. God reps are so clueless about what goes on real in the real world.
Click to expand...

Since when did registrational studies reflect real world clinical practice? They simply don't and that could be the subject of a whole different debate.

Now whether this drug gets approved or not is pure conjecture and when this board is concerned - idiotic comment.

Layoffs on the other hand are inevitable - whether dapa gets approved or not
 




Not only is Dapa not going to be safe, but the efficacy is weak. Read the studies, same as all other add ons, depends on which step, previous med. history etc. etc. We are going to run into the same problem that we have with ONGLYZNATCH. If it is not used perfectly in the appropriate patient (which is crap anyway) it might not give the A1C reductions that we have been overhyping from day one. Not to mention that the oral diabetes market is becoming a crowded house. The consensus is moving rapidly towards early insulin therapy. Oh yes, and please don't forget to have your patients stock up on cranberry juice and levaquin. Because they are probably going to have recurrent UTI's.

If DAPA makes it to the market, it will probably do 40 mil. in the first year and peak at 200 mil. before it gets black listed because of post marketing events.

If you want to stay in the diabetes market for the long haul (whatever that means) go sell insulin or join a biotech firm.
 
















Top Bottom
Back
Quote